ERICA LOPEZ: Open Payments
NPI 1346880275 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 34 payments from 17 companies in 2025. Trend: 2023 $806 · 2024 $1,206 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $182 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Dexcom, Inc. | 2 | $61 |
| Exact Sciences Corporation | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| ABBVIE INC. | 2 | $43 |
| Astellas Pharma US Inc | 2 | $43 |
| Stryker Corporation | 1 | $34 |
| Lilly USA, LLC | 1 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
Products named: JARDIANCE, Ozempic, Dexcom G6 Transmitter, Wegovy, Veozah, MAKO, VOQUEZNA, INSPIRE.
Industry payments across IL — which companies pay providers there.
